Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -39.68% is 96% below its 5-year average of -20.28%, near the low end of its 5-year range (-39.68%–1.87%).
34.42% below its 12-month average of -29.52%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -9.90%.
RETURN ON ASSETS (ROA)
-39.68%
RETURN ON ASSETS (ROA) AVG TTM
-29.52%
RETURN ON ASSETS (ROA) AVG 3Y
-26.86%
RETURN ON ASSETS (ROA) AVG 5Y
-20.28%
RETURN ON ASSETS (ROA) AVG 10Y
-115.79%
RETURN ON ASSETS (ROA) AVG 15Y
-19.02%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-34.42%
CURRENT VS 3Y AVG
-47.70%
CURRENT VS 5Y AVG
-95.63%
CURRENT VS 10Y AVG
+65.73%
CURRENT VS 15Y AVG
-108.58%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.73%
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
-29.15%
vs the sector median at left
Cosmos Health Inc.
Market Cap
$17.64M
Return on Assets (ROA)
-39.68%
TTM Avg
-29.52%
3Y Avg
-26.86%
5Y Avg
-20.28%
Market Cap
$17.19M
Return on Assets (ROA)
-49.72%
TTM Avg
-28.29%
3Y Avg
-39.08%
5Y Avg
-40.04%
Market Cap
$18.60M
Return on Assets (ROA)
-548.74%
TTM Avg
-346.44%
3Y Avg
-242.08%
5Y Avg
-167.09%
Market Cap
$17.01M
Return on Assets (ROA)
-59.70%
TTM Avg
-56.25%
3Y Avg
-61.89%
5Y Avg
-61.99%
Market Cap
$16.98M
Return on Assets (ROA)
-30.06%
TTM Avg
65.41%
3Y Avg
-56.95%
5Y Avg
-76.50%
Market Cap
$18.86M
Return on Assets (ROA)
-64.55%
TTM Avg
-0.45%
3Y Avg
-55.72%
5Y Avg
-45.67%
Market Cap
$16.76M
Return on Assets (ROA)
-98.29%
TTM Avg
-314.03%
3Y Avg
-259.71%
5Y Avg
-198.18%
Market Cap
$16.75M
Return on Assets (ROA)
-67.58%
TTM Avg
-90.98%
3Y Avg
-83.38%
5Y Avg
-70.12%
Market Cap
$16.48M
Return on Assets (ROA)
-116.60%
TTM Avg
-66.28%
3Y Avg
-71.56%
5Y Avg
-63.10%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cosmos Health Inc. (COSM) | $17.64M | -39.68% | -29.52% | -26.86% | -20.28% |
| Lipocine Inc. (LPCN)vs › | $17.19M | -49.72% | -28.29% | -39.08% | -40.04% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.60M | -548.74% | -346.44% | -242.08% | -167.09% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | -59.70% | -56.25% | -61.89% | -61.99% |
| PAVmed Inc. (PAVM)vs › | $16.98M | -30.06% | 65.41% | -56.95% | -76.50% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.86M | -64.55% | -0.45% | -55.72% | -45.67% |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | -98.29% | -314.03% | -259.71% | -198.18% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | -67.58% | -90.98% | -83.38% | -70.12% |
| Dyadic International, Inc. (DYAI)vs › | $16.48M | -116.60% | -66.28% | -71.56% | -63.10% |
| NextCure, Inc. (NXTC)vs › | $19.25M | -188.98% | -90.06% | -67.42% | -51.71% |
ROA
-39.7%
ROE
-118.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -29.24% |
| 2024-12-31 | -29.80% |
| 2023-12-31 | -28.09% |
| 2022-12-31 | -20.33% |
| 2021-12-31 | -16.11% |
| 2020-12-31 | 1.87% |
| 2019-12-31 | -13.81% |
| 2018-12-31 | -43.78% |
| 2017-12-31 | -58.17% |
| 2016-12-31 | -19.27% |
| 2015-12-31 | -1016.99% |
| 2014-12-31 | 83.55% |
| 2013-12-31 | 28.44% |
| 2012-12-31 | 0.00% |
| 2011-07-31 | -1110.68% |
| 2010-07-31 | -806006.17% |
| 2009-07-31 | 0.00% |
